-- The NEW Official Alizyme Thread! --

Gambill (Post 10579) thanks; and a Happy New Year to you and everyone else, including all at AZM.

Everything is pointing to 2005 being a great year for the Company and share price, for obvious reasons of anticipated newsflow on out-licensing deals for COLAL-PRED and the potential blockbuster Renzapride during the next 12 weeks, advanced pipeline and comparatively low risk. Also out-licensing of the potential blockbuster ATL-962 in H2 2004 or H1 2005. Possibly the best UK biotech prospect for 2005 imo.